Carolyn Young

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

David Rog, Turo Nurmikko, Tim Friede et al. · Neurology · 2005 · 678 citations

Nursing, Neurology, Pharmacotherapy +14

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Vittorio Martinelli, M. Rodegher, Lucia Moiola et al. · The Lancet · 2009 · 587 citations

Medicine, Neurology, Pharmacology +8

Achieving Saturation in Thematic Analysis: Development and Refinement of a Codebook

Hikari Ando, Rosanna Cousins, Carolyn Young · Comprehensive Psychology · 2014 · 572 citations · Full text

Social Sciences, Human Resource Management, Categorical Data Analysis +14

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

The effect of anti-α4 integrin antibody on brain lesion activity in MS

Niall Tubridy, P. O. Behan, Rudy Capildeo et al. · Neurology · 1999 · 308 citations

Pharmacy, Neurology, Pharmacotherapy +16